Conclusion: This study identifies the GDF15–GFRAL signaling axis as a critical regulator of oxidative stress and immune evasion in HNSCC and demonstrates that the novel small-molecule SM-2 effectively targets this pathway, highlighting its potential as a promising therapeutic strategy. The gene discussed is GDF15; the disease is head and neck squamous cell carcinoma.